Journal of the American College of Cardiology
National Heart, Lung, and Blood Institute working group on emergency department management of acute heart failure: research challenges and opportunities.
Effects of the adenosine A1 receptor antagonist rolofylline on renal function in patients with acute heart failure and renal dysfunction: results from PROTECT (Placebo-Controlled Randomized Study of the Selective Adenosine A1 Receptor Antagonist Rolofylli
Bile salts for the treatment of heart failure: out on a limb for a gut feeling?
Effect of serelaxin on cardiac, renal, and hepatic biomarkers in the Relaxin in Acute Heart Failure (RELAX-AHF) development program: correlation with outcomes.
The predictive value of short-term changes in hemoglobin concentration in patients presenting with acute decompensated heart failure.
Effect of serelaxin on mode of death in acute heart failure: results from the RELAX-AHF study.
Reply: Mode of Death Prevention by Serelaxin.
Acute Treatment With Omecamtiv Mecarbil to Increase Contractility in Acute Heart Failure: The ATOMIC-AHF Study.
Influence of Sacubitril/Valsartan (LCZ696) on 30-Day Readmission After Heart Failure Hospitalization.
Hospitalization for Recently Diagnosed Versus Worsening Chronic Heart Failure: From the ASCEND-HF Trial.
